Ignite Creation Date:
2025-12-25 @ 2:38 AM
Ignite Modification Date:
2025-12-28 @ 11:45 PM
Study NCT ID:
NCT06207734
Status:
RECRUITING
Last Update Posted:
2025-05-01
First Post:
2024-01-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Discontinuation of CDK4/6 Inhibitors in Patients With Metastatic HR Positive, HER2 Negative Breast Cancer
Sponsor:
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01-17
Start Date Type:
ACTUAL
Primary Completion Date:
2027-01-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-07-10
Completion Date Type:
ESTIMATED
First Submit Date:
2024-01-03
First Submit QC Date:
None
Study First Post Date:
2024-01-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-30
Last Update Post Date:
2025-05-01
Last Update Post Date Type:
ACTUAL